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Late open conversion and explantation of
abdominal aortic stent grafts
Clayton J. Brinster, MD, Ronald M. Fairman, MD, Edward Y. Woo, MD, Grace J. Wang, MD,
Jerffrey P. Carpenter, MD, and Benjamin M. Jackson, MD, Philadelphia, Pa
Objectives: To evaluate indications for, operative strategy during, and outcomes following late open surgical conversion
following endovascular aneurysm repair (EVAR).
Methods: Between 2002 and 2009, patients undergoing open abdominal aortic aneurysm repair at a university hospital
were entered prospectively into a database which was examined to identify patients undergoing open conversion>30 days
after EVAR.
Results: Over 7 years, 21 patients required late open conversion of EVAR. The average patient age was 75 years (range,
59-88), and there were 16 male (76%) patients. The mean interval to conversion was 33.4 months (range, 2-73). Eight
patients (38%) presented with proximal type I endoleak; 4 patients (19%) presented with type II endoleak and aneurysm
expansion; 5 patients (24%) presented with graft migration and aneurysm expansion; and 5 patients (24%) presented with
de novo visceral aneurysms. Rupture (1) and infection (1) were also observed. There were five (24%) emergent cases. Most
patients (12/21, 57%) hadmore than one reason for conversion. There were no perioperative deaths; three patients (14%)
had major complications. Grafts requiring conversion were AneuRx (6; Medtronic AVE, Santa Rosa, Calif), Zenith (6;
Cook Inc, Bloomington, Ind), Talent (3; Medtronic), Excluder (2; W. L. Gore, Flagstaff, Ariz), Anaconda (1; TERUMO
Corp, Ann Arbor, Mich), Ancure (1; Guidant, Menlo Park, Calif), Quantum LP (1; Cordis Corp, Miami Lakes, Fla), and
Powerlink (1; Endologix, Irvine, Calif). The surgical approach was retroperitoneal in 16 (76%) and transperitoneal in
four (19%) patients. Initial proximal aortic control was supraceliac (9/21), suprarenal (7/21), or infrarenal (5/21), with
stepwise distal clamping to reduce ischemic time. Complete endograft removal was performed in 17/21 patients; in 4/21
the distal anastomosis was performed to the endograft after proximal segment explantation. Reconstruction was
completed with tube (19/21) or aortoiliac (2/21) grafts; in one case, homograft was used. Mean intraoperative blood
loss was 1.9 L (range, 0.4-6.5 L), mean intensive care unit (ICU) stay was 3 days (range, 2-6), and the mean hospital stay
was 10 days (range, 4-39).
Conclusions: While technically challenging, delayed open conversion of EVAR can be accomplished with low morbidity
and mortality in both the elective and emergent settings. These results reinforce the justification for long-term
surveillance of endografts following EVAR. (J Vasc Surg 2011;54:42-7.)
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oSince first reported nearly 20 years ago,1 endovascu-
lar aortic repair (EVAR) has been established as a safe
and effective alternative to open surgical repair in the
treatment of infrarenal abdominal aortic aneurysms
(AAAs). The long-term durability of EVAR remains a
concern, however, and the potential for adverse events
related to endograft migration, endoleak, or endograft
failure requires lifelong surveillance. Although secondary
procedures are required in up to 27% of patients follow-
ing EVAR, endovascular reintervention is therapeutic in
the majority of these cases.2-5
Late open surgical conversion following EVAR is re-
quired in cases of endograft infection and aneurysm rup-
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42ure, as well as in cases of aneurysm expansion, graft migra-
ion, limb occlusion, or endoleak that are refractory to
econdary endovascular intervention.3,4,6-8 Open conver-
ion is reported in up to 5% of cases after EVAR at experi-
nced centers, and the associated morbidity and mortality
ates with secondary conversion can be significantly higher
han those encountered with primary open repair.6,7,9-13
We report a single university hospital experience with
ate conversion of previous EVAR to review the current
ndications and operative strategy for open conversion, as
ell as to assess patient outcomes following explantation of
ndografts and subsequent aortic reconstruction.
ETHODS
Patients undergoing open and endovascular AAA re-
air at our institution were entered prospectively into a
urgical database. Those requiring open conversion of pre-
ious EVAR between 2002 and 2009 were identified ret-
ospectively. Patients undergoing graft explantation and
pen abdominal aortic reconstruction30 days after initial
VAR were included in this analysis. The indication for
pen conversion, type of endograft, patient demographics,
nstitution of initial operation, operative technique, intra-
perative blood loss, length of stay, and postoperative
orbidity and mortality were reviewed. Operative data
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Volume 54, Number 1 Brinster et al 43were analyzed for anatomic surgical approach, site and
duration of aortic cross-clamping, endograft status, and
technique of aortic reconstruction. Statistical analysis was
performed with SPSS (SPSS Inc, Chicago, Ill). Follow-up
was conducted through a retrospective electronic chart
review.
RESULTS
Between 2002 and 2009, 21 patients required late
open conversion of previous EVAR at a single institu-
tion. The average patient age was 75 years (range, 59-
88), and there were 16 male patients (76%). Within this
group, 12/21 (57%) underwent initial EVAR at our
institution. During the same time period, 1273 EVARs
were performed, for an estimated institutional conver-
sion rate of 0.9%.
Secondary endovascular interventions were attempted
in 14/21 (67%) as salvage procedures prior to subsequent
conversion. In the secondary treatment of type I endoleak
in six patients prior to open conversion, proximal wall
stents were placed in four patients, and proximal percuta-
neous transluminal angioplasty (PTA) alone was performed
in two patients. In each of these cases, the endoleak per-
sisted, and each case required conversion. In two cases of
distal stent graft migration, proximal PTA and extension
cuff stent placement was attempted but failed to adequately
seal and exclude the aneurysm sac. Two cases of initial stent
graft kinking underwent conversion after PTA of the native
stent graft was unsuccessful.
The mean interval to open surgical conversion follow-
ing EVAR was 33.4 months and the median time to con-
version was 30 months (range, 2-73). Table I summarizes
the indications for conversion. The majority of patients
(12/21, 57%) presented with more than one indication for
conversion, and the average number of indications per
patient was 2.0 (range, 1-3). Open conversions were per-
formed by three different surgeons. Four conversions were
Table I. Indications for late open conversion following
EVAR
Total patients 21
Endoleak 12 (57%)
Type I 8 (38%)
Type II 4 (19%)
Aneurysm expansion 9 (43%)
With endoleak 8 (38%)
Without endoleak 1 (5%)
Graft migration 5 (24%)
With aneurysm expansion 5 (24%)
With kinking 2 (10%)
De novo visceral aneurysm 5 (24%)
Aneurysm rupture 1 (5%)
Endograft infection 1 (5%)
Multiple indications 12 (57%)
Average no. indications/patient 2.0
EVAR, Endovascular aortic repair.performed for type II endoleak. In each of these cases, wepeated coil embolization attempts failed to effectively
reat the endoleak and prevent aneurysm expansion.
Five conversions were performed on an emergent basis.
he patient who presented with rupture had developed
cute abdominal pain over the course of several hours, was
iagnosed with a rupture involving the renal arteries by
omputed tomography angiography (CTA), and was found
uring exploration to have a penetrating atherosclerotic
lcer (PAU) at the proximal aspect of the rupture. The
atient experienced no prior signs or symptoms of aneu-
ysm expansion, endoleak, or PAU. Four other conversions
ere performed on an emergent basis: one case of graft
nfection, one case of a symptomatic, expanding type I
ndoleak, and two cases of graft migration with distal limb
inking. Adequate follow-up had been continued in the
ases of infection, rupture, and type I endoleak, while the
atients presenting with graft migration and kinking had
een lost to follow-up after their 4- and 5-year postopera-
ive surveillance CTA, respectively.
Specific grafts that required open conversion included
neuRx (Medtronic AVE, Santa Rosa, Calif) in six patients,
enith (Cook Inc, Bloomington, Ind) in six patients, Tal-
nt (Medtronic) in three patients, Excluder (W. L. Gore,
lagstaff, Ariz) in two patients, and Anaconda (TERUMO
orp, Ann Arbor, Mich), Ancure (Guidant, Menlo Park,
alif), Quantum LP (Cordis Corp, Miami Lakes, Fla), and
owerlink (Endologix, Irvine, Calif) in one patient each.
Surgical approach included left retroperitoneal expo-
ure in 17 (81%) patients and transperitoneal exposure in
our (19%) patients (Table II). One case was performed
hrough a transperitoneal exposure to allow visceral explora-
ion in the case of aortic rupture with suspected malperfusion
nd bowel ischemia. Two cases were performed through a
ransperitoneal exposure because these patients had under-
one previous left retroperitoneal procedures, and one
ase, completed early in our experience, was performed
hrough a transperitoneal approach based on surgeon pref-
rence. Initial proximal aortic control was obtained by
ross-clamping the supraceliac (9/21), suprarenal (7/21),
r infrarenal (5/21) aorta, with stepwise distal clamping
uring aortic reconstruction to reduce visceral and renal
schemic time. The five patients requiring infrarenal clamp-
ng had severe graft kinking, migration, or hostile neck
natomy that precluded endovascular salvage. Endografts
able II. Surgical approach and technique
natomic approach
Retroperitoneal 17/21 (81%)
Transperitoneal 4/21 (19%)
ndograft status
Complete removal 17/21 (81%)
Incorporated into distal repair 4/21 (19%)
nfrarenal aortic reconstruction
Tube graft to bifurcationa 15/21 (71%)
Tube graft to preserved endograft 4/21 (19%)
Aortobiiliac graft 2/21 (10%)
Homograft was used in one case.ith suprarenal fixation required supraceliac aortic control.
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July 201144 Brinster et alTo reduce the risk of intimal injury and visceral ischemic
time in cases of active suprarenal fixation not amenable to
manual explantation, wire cutters were used to cut the
endograft in a circumferential manner in most cases, allow-
ing the endograft and its respective barbs to be removed.
Perioperative outcome as related to initial aortic cross-
clamp site is presented in Table III.
Complete endograft removal was performed in 17/21
patients (Table II). In 4/21 patients, the iliac limbs or
distal components of the endograft were densely incorpo-
rated, and, therefore, the distal anastomosis in these cases
was performed to the remaining distal endograft after prox-
imal segment explantation. Aortic reconstruction was com-
pleted with an infrarenal tube graft sewn to the aortic
bifurcation in 15/21 patients, a tube graft sewn to a
preserved distal endograft component in 4/21 patients, or
with a bifurcated aortoiliac graft in 2/21 patients. A ho-
mograft was used in one patient who presented with en-
dograft infection. A left renal artery bypass was performed
in one patient who required supraceliac clamping based on
aneurysmal dilatation of the pararenal aorta and left renal
artery ostium, and one patient required a celiac artery
bypass after an isolated celiac artery aneurysm was diag-
nosed intraoperatively.
Themean estimated intraoperative blood loss was 1.9 L
(range, 0.4-6.5L). The mean intensive care unit (ICU) stay
was 3 days (range, 2-6), and the mean hospital stay was 10
days (range, 4-39). There were no observed cases of new
onset renal failure, and no patients required dialysis. There
was no statistically significant difference in these outcomes
among aortic cross-clamp groups, among indication for
conversion groups, or among individual patients within
these groups (Table III).
Three patients (15%) had major complications. One
patient developed right lower extremity ischemia on post-
operative day one following a retroperitoneal dissection,
supraceliac clamping for proximal aortic control, complete
explantation of the endograft, and aortic reconstruction
with a tube graft sewn to the infrarenal aorta proximally and
the aortic bifurcation distally. Angiogram revealed an oc-
clusive intimal flap, and common iliac artery angioplasty
and stenting were performed. Another patient developed a
Table III. Patient characteristics by initial aortic cross-clam
Initial clamp site Supraceliac
Patients (n  21) 9 (43%)
Average visceral ischemic time 15 minutes
Average renal ischemic time 19 minutes
Mean EBL 2.6 (400-6.0)
Mean ICU stay 3 d (2-5)
Mean hospital stay 14 d (7-39)
Major complicationsb 2/9 (22%)
Mortality 0/9 (0%)
ANOVA, Analysis of variance; EBL, estimated blood loss; ICU, intensive ca
aP is from ANOVA analysis.
bComplications of renal failure or visceral ischemia were not observed.small bowel obstruction requiring a laparotomy and lysis of rsingle band adhesion. This patient had a history of intra-
bdominal surgery, and the removal of the endograft and
ortic reconstruction were performed through a retroperi-
oneal approach. A third patient developed an upper gas-
rointestinal bleed (GIB) in the early postoperative period
equiring esophagogastroduodenoscopy. This patient un-
erwent open conversion through a retroperitoneal ap-
roach with infrarenal aortic cross-clamping, and the etiol-
gy of his GIB was unclear.
There were no deaths in the perioperative or postoper-
tive periods. Over an average follow-up of 50.2 months
range, 18-92), there have been no reported cases of aneu-
ysm rupture, limb ischemia, renal failure, need for late
eoperation, or mortality.
ISCUSSION
EVAR has been established as a safe and effective
lternative to open surgical repair in the treatment of infra-
enal AAAs. Although the early morbidity and mortality
ates reported with EVAR are lower than those experienced
ith open surgical repair,8,14,15 long-term surveillance is
equired following EVAR based on the frequent need for
econdary intervention to achieve or maintain aneurysmal
xclusion.3,5 In addition, despite advances in endograft
echnology and the increasing clinical experience with
VAR and endovascular salvage procedures, conversion
o open surgical repair is reported in 0.6% to 4.5% of
atients undergoing EVAR, regardless of the type of
ndograft.8-12,14,16,17
Late surgical conversion with complete endograft re-
oval and aortic reconstruction with a standard tube or
ifurcated surgical graft has been associated with a high mor-
ality when compared to elective AAA repair.4,12,13 An early
eries reported in 1999 by May and colleagues6 noted a 17%
ortality following open conversion, and other early series
oted morality rates ranging from 20% to 43%.2,4,11,13 More
ecent series have reported mortality rates between 0% and
2%.14,18-20 In the largest series of this kind, Kelso et al12
ecently reported an overall mortality of 19% in 41 patients,
ith a mortality of 9% in patients presenting without rupture.
The mortality and morbidity rates in this series com-
are favorably to those reported in other similar se-
te
Suprarenal Infrarenal P valuea
7 (33%) 5 (24%) —
— — —
23 minutes — .77
.5 L (400-2.8) 1.4 L (600-2.0) .20
3 d (2-4) 3 d (2-6) .67
9 d (6-10) 8 d (4-12) .29
0/7 (0%) 1/5 (20%) .83
0/7 (0%) 0/5 (0%) .99
t.p si
1
re uniies.2,4,6,10,12,18,19 The absence of mortality and low
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Volume 54, Number 1 Brinster et al 45morbidity rate can most likely be attributed to two
influential factors. First, 16 of 21 cases were elective: one
patient presented with rupture, one with endograft in-
fection, and none presented with aortoenteric fistula. In
most other large series of late conversion, rupture, infec-
tion, and aortoenteric fistula led to increased intra- and
preoperative mortality when compared to elective AAA
repair.7,9,12 Second, some authors have attributed the
high morbidity and mortality seen with late conversion
to extended supravisceral aortic cross-clamp time and
have advocated other approaches.18-21 The visceral and
renal ischemia times and intraoperative blood loss were
low in this series compared to others,11,12,19 however,
and no patients required dialysis.
The morbidity and mortality rates experienced in the
emergent setting in most series of open conversion remain
high when compared to those performed in the elective
setting. Most recent series, including this one, report mor-
tality rates with elective surgical conversion of near or
10%.7,12,18,20,24 These combined results reinforce the
need for long-term surveillance following EVAR, allowing
timely identification of graft related pathology and elective,
rather than emergent, surgical conversion. EVAR surveil-
lance is valuable because the ultimate correction for a failed
endograft (endoleak, sac expansion, migration) is open
conversion. As previously placed endografts age, and an
increasing array of interventionalists perform EVAR, the
need for open conversion can be expected to persist or
increase, further emphasizing the need for close, long-term
follow-up. Our preferred surveillance regimen following
EVAR consists of CTA at 1, 6, and 12 months, then yearly
thereafter.
The majority of patients underwent attempted endo-
vascular reintervention prior to open conversion in this
series. The remaining patients were not candidates for
endovascular procedures based on the presence of pararenal
aneurysms, infection, severe graft kinking, or rupture. Al-
though our institutional conversion rate is difficult to cal-
culate with certainty because patients may seek follow-up
care at other hospitals, our observed rate of about 1.0%
is consistent with reports in the literature from other
large centers.3,12,19,24
Endoleak with concomitant aneurysm enlargement,
graft migration, or loss of proximal fixation was the most
common overall indication for open conversion, which is
consistent with the experience of other centers.3,4,7,9,12,21
In cases of isolated, asymptomatic type II endoleak, endo-
vascular reintervention was performed initially. Open con-
version was reserved for those cases of refractory type II
endoleak that presented with continued aneurysm expan-
sion or with the development of symptoms. Themajority of
patients presented with more than one indication for con-
version, and these results are similar to other large series in
the literature.3,7,9,12
Surgical conversion of EVAR presents a unique array of
technical challenges. Among these, the endograft itself and
any associated secondary endovascular salvage devices, such
as embolization coils and proximal or distal extension cuffs, tncrease the difficulty of dissection and the establishment of
dequate vascular control.7,12,23 Patients presenting for
ate open conversion by definition have advanced aortic
isease, and the majority of patients in this and other
omparable series had periaortic inflammation, active en-
oleaks, and enlarging aneurysms. Over one-third of
atients in this series presented for conversion with
ndografts reliant on active suprarenal fixation, which
equire additional dissection and supravisceral aortic
lamping to achieve proximal aortic control.
Several surgical techniques have been described in the
anagement of EVAR conversion. Both transperitoneal19
nd retroperitoneal6 exposures have been used with suc-
ess. In the current experience, a left retroperitoneal ap-
roach was used routinely. For cases in which right com-
on iliac artery access was essential or in patients with
revious left retroperitoneal surgery, a transperitoneal ap-
roach was used. Although the sample size of the series
imits somewhat the power of comparison and analysis,
here was no significant difference in estimated blood loss
r respective cross-clamp or operative times between these
wo groups.
The majority of cases in this series required supraceliac
r suprarenal cross-clamping to secure adequate aortic con-
rol and safe access to the proximal extent of the endograft,
nd variations of this approach have been utilized by several
roups with good results.10,12,22,25 In these cases, the
roximal and distal dissection are completed, the proximal
lamp applied, and the aneurysm sac opened in longitudinal
ashion. The proximal endograft neck is thenmobilized and
emoved. In our experience, there was little proximal en-
oluminal incorporation in most cases, and endografts with
assive fixation were removed en totalwith relative ease and
inimal intimal denuding. In cases of active fixation not
menable to simple manual explantation, wire cutters were
sed to release the body of the endograft from its respective
arbs in a circumferential manner, and the barbs were then
ently removed, avoiding intimal injury. After proximal
ndograft mobilization, the proximal aortic clamp is moved
n a stepwise distal fashion if possible. We have found
emoval of suprarenal stent graft components to be feasible
nd safe when wire cutters are used according to this
tandardized approach. Each individual case merits unique
onsiderations, however, and if densely adherent proximal
arbs are present, transection of the graft with incorpora-
ion of the proximal cuff into the proximal anastomosis is
ertainly a reasonable approach.
The authors prefer to remove the entire endograft if
easible and safe. When intraluminal stent graft compo-
ents were found to be densely adherent or extending to
he external iliac artery in four patients, they were incorpo-
ated into the distal anastomosis. Several other groups have
ad success with partial endograft removal and hybrid
econstruction utilizing distal or proximal endograft seg-
ents.7,12,19,20,22 Jimenez et al20 reported no deaths in a
roup of 12 patients undergoing late open conversion, with
ine of these patients undergoing hybrid aortic reconstruc-
ion: eight with retention of distal endograft components,
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tion, this group described the use of transendograft balloon
occlusion in 11/12 patients to achieve proximal aortic
control after opening the aneurysm sac. In that series, after
the proximal endograft was removed, an infrarenal cross-
clamp was applied and reconstruction undertaken. Nabi
and colleagues18 recently described their experience with
12 cases of late open conversion for proximal type I en-
doleak alone, in which six patients were treated successfully
with total endograft preservation after external suturing of
the aortic neck, without the need for aortic cross-clamping.
CONCLUSION
Delayed open conversion of EVAR can be accom-
plished with low morbidity and mortality in both the
elective and emergent settings. These results reinforce
the justification for long-term surveillance of endografts
following EVAR. Although these cases present unique
technical challenges, the current series demonstrates that
excellent outcomes are possible.
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